Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
644 | 3132 | 36.3 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HELICOBACTER PYLORI | Author keyword | 150 | 11% | 39% | 1235 |
2 | QUADRUPLE THERAPY | Author keyword | 123 | 89% | 2% | 56 |
3 | CLARITHROMYCIN RESISTANCE | Author keyword | 91 | 84% | 2% | 49 |
4 | CLARITHROMYCIN | Author keyword | 90 | 26% | 9% | 293 |
5 | TRIPLE THERAPY | Author keyword | 75 | 42% | 4% | 139 |
6 | ERADICATION | Author keyword | 58 | 18% | 9% | 291 |
7 | HELICOBACTER | Journal | 56 | 20% | 8% | 244 |
8 | ERADICATION RATE | Author keyword | 53 | 78% | 1% | 35 |
9 | RANITIDINE BISMUTH CITRATE | Author keyword | 53 | 78% | 1% | 35 |
10 | METRONIDAZOLE | Author keyword | 32 | 14% | 7% | 208 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HELICOBACTER PYLORI | 150 | 11% | 39% | 1235 | Search HELICOBACTER+PYLORI | Search HELICOBACTER+PYLORI |
2 | QUADRUPLE THERAPY | 123 | 89% | 2% | 56 | Search QUADRUPLE+THERAPY | Search QUADRUPLE+THERAPY |
3 | CLARITHROMYCIN RESISTANCE | 91 | 84% | 2% | 49 | Search CLARITHROMYCIN+RESISTANCE | Search CLARITHROMYCIN+RESISTANCE |
4 | CLARITHROMYCIN | 90 | 26% | 9% | 293 | Search CLARITHROMYCIN | Search CLARITHROMYCIN |
5 | TRIPLE THERAPY | 75 | 42% | 4% | 139 | Search TRIPLE+THERAPY | Search TRIPLE+THERAPY |
6 | ERADICATION | 58 | 18% | 9% | 291 | Search ERADICATION | Search ERADICATION |
7 | ERADICATION RATE | 53 | 78% | 1% | 35 | Search ERADICATION+RATE | Search ERADICATION+RATE |
8 | RANITIDINE BISMUTH CITRATE | 53 | 78% | 1% | 35 | Search RANITIDINE+BISMUTH+CITRATE | Search RANITIDINE+BISMUTH+CITRATE |
9 | METRONIDAZOLE | 32 | 14% | 7% | 208 | Search METRONIDAZOLE | Search METRONIDAZOLE |
10 | ERADICATION THERAPY | 27 | 32% | 2% | 70 | Search ERADICATION+THERAPY | Search ERADICATION+THERAPY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRIPLE THERAPY | 576 | 53% | 25% | 768 |
2 | QUADRUPLE THERAPY | 333 | 80% | 7% | 210 |
3 | AMOXICILLIN | 253 | 33% | 20% | 625 |
4 | METRONIDAZOLE RESISTANCE | 235 | 60% | 8% | 255 |
5 | CLARITHROMYCIN | 206 | 27% | 21% | 654 |
6 | CLARITHROMYCIN RESISTANCE | 193 | 66% | 6% | 181 |
7 | OMEPRAZOLE PLUS AMOXICILLIN | 171 | 96% | 2% | 52 |
8 | RANITIDINE BISMUTH CITRATE | 153 | 79% | 3% | 99 |
9 | ERADICATION | 146 | 15% | 28% | 881 |
10 | DUODENAL ULCER | 120 | 17% | 20% | 642 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HELICOBACTER | 56 | 20% | 8% | 244 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
H pylori antibiotic resistance: prevalence, importance, and advances in testing | 2004 | 424 | 131 | 98% |
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report | 2012 | 504 | 291 | 21% |
Review: Efficacy and Safety of Hybrid Therapy for Helicobacter pylori Infection: A Systematic Review and Meta-analysis | 2015 | 2 | 30 | 100% |
Worldwide H. pylori Antibiotic Resistance: a Systematic Review | 2010 | 109 | 42 | 100% |
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure | 2006 | 181 | 26 | 92% |
Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment | 2008 | 144 | 30 | 73% |
Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective | 2015 | 2 | 109 | 79% |
New concepts of resistance in the treatment of Helicobacter pylori infections | 2008 | 112 | 65 | 82% |
Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children | 2009 | 131 | 33 | 70% |
A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates | 1999 | 241 | 34 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | URGENT ENDOSCOPY UNIT | 8 | 100% | 0.2% | 5 |
2 | REFERENCE HELICOBACTER PYLORI | 7 | 64% | 0.2% | 7 |
3 | UNITAT MALALTIES DIGEST | 6 | 47% | 0.3% | 9 |
4 | UNIV SOCIAL MED HEALTHCARE MANAGEMENT | 4 | 75% | 0.1% | 3 |
5 | HELICOBACTER REFERENCE UNIT | 3 | 31% | 0.3% | 8 |
6 | GASTROENTEROL MICROBIOL | 3 | 50% | 0.1% | 4 |
7 | CASA CURA PIERANGELI | 2 | 67% | 0.1% | 2 |
8 | HELICOBACTER PYLORI CENT | 2 | 67% | 0.1% | 2 |
9 | GASTROINTESTINAL CLIN E23 | 2 | 50% | 0.1% | 3 |
10 | REFERENCE CAMPYLOBACTER HELICOBACTER | 2 | 50% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197697 | LG21//MUSCADINE GRAPE SKIN//SECT BIOMEMBRANES |
2 | 0.0000172290 | HELICOBACTER PYLORI//UREA BREATH TEST//C 13 UREA BREATH TEST |
3 | 0.0000110304 | GASTRIC METAPLASIA//DUODENAL GASTRIC METAPLASIA//PARIETAL INDEX |
4 | 0.0000092414 | LEAD FREE BRONZE//COMPOUND SEPARATION METHOD//BIPP |
5 | 0.0000074641 | ATROPHIC GASTRITIS//INTESTINAL METAPLASIA//PEPSINOGEN |
6 | 0.0000073015 | OMEPRAZOLE//LANSOPRAZOLE//PANTOPRAZOLE |
7 | 0.0000066119 | IDIOPATHIC PEPTIC ULCER//DUODENAL PEPTIC ULCER//ATTITUDE TO THE DISEASE |
8 | 0.0000061997 | FUNCTIONAL DYSPEPSIA//DYSPEPSIA//GASTRIC ACCOMMODATION |
9 | 0.0000058386 | CAGA//VACA//HELICOBACTER PYLORI |
10 | 0.0000056324 | EXTRAGASTRIC DISEASES//EXTRAGASTRIC DISEASE//PULM MED 9 |